| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | |
| Description | CD19 molecule | ||||
| Gene symbol | MS4A1 | Synonyms | B1, Bp35, CD20, CVID5, FMC7, LEU-16, S7 | Type of gene | protein-coding |
| Chromosome | 11 | Map location | 11q12.2 | dbXrefs | |
| Description | membrane spanning 4-domains A1 | ||||
| GTO ID | GTC2264 |
| Trial ID | NCT04186520 |
| Disease | Mantle Cell Lymphoma | Chronic Lymphocytic Leukemia | Non-Hodgkin's Lymphoma | Central Nervous System Lymphoma | Follicular Lymphoma | Diffuse Large B-Cell Lymphoma | Marginal Zone Lymphoma |
| Altered gene | CD19|CD20 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CD19/CD20 CAR-T cells |
| Phase | Phase1|Phase2 |
| Recruitment status | Recruiting |
| Title | CAR-20/19-T Cells in Patients With Relapsed Refractory B Cell Malignancies |
| Year | 2020 |
| Country | United States |
| Company sponsor | Medical College of Wisconsin |
| Other ID(s) | PRO00037171 |
| Cohort 1 | |||||||||
|
|||||||||